Searches of MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials were used to identify 15 randomized controlled trials that compared CRRT with IRRT in a total of 1,550 patients.

The abstract of the RENAL Replacement Therapy study concludes that in critically ill patients with acute kidney injury, treatment with higher-intensity continuous renal replacement therapy did not ...

研究人员利用 MIMIC-IV 数据库开展回顾性研究。结果显示，CRRT 起始时间与 28 天死亡率无显著关联，但非肾 SOFA 评分低的患者尽早 RRT 临床结局更好。该研究为后续探索提供方向。 在重症监护室里，急性肾损伤（AKI）就像一颗隐藏在患者身体里的 “定时炸弹 ...

All patients undergoing CRRT while on ECLS between 2005 and 2010 at Seattle Children's Hospital (n = 42) were identified by a retrospective review of a prospectively maintained institutional database.

Talphera (TLPH) announced its agreement with the FDA to reduce the size of the NEPHRO CRRT study to 70 patients from the 166 previously ...

CFO Raffi Asadorian reported that Talphera reduced Q4 2024 operating expenses to $3 million from $4.6 million in Q4 2023, with further cash operating expenses for 2025 projected at $18-$19 million.

Though the CRRT solutions may require patient-specific adjustments, the work group determined that a standardized system for prescribing, processing, compounding, and verifying CRRT solutions was ...

Talphera Inc (TLPH) secures significant investment and FDA approvals, while navigating challenges in clinical trials and ...

Welcome to the Talphera fourth quarter and full year 2024 financial results conference call. This call is being webcast live via the Events page of the Investors section of Talphera's website, You ...

Main course: Didactic and interactive sessions to cover basics of CRRT (e.g., patient selection, modality, timing, dose, prescription, anticoagulation, access, membrane, circuit, alarms, ...

Q4 2024 Earnings Call Transcript March 31, 2025 Talphera, Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.21. Operator: Welcome to the Talphera Fourth Quarter and Full ...

The recent announcements of the FDA’s approval to reduce the study size to 70 patients, the private placement financing, and FDA-agreed study ...